These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Risk of invasive cervical cancer after atypical glandular cells in cervical screening: nationwide cohort study. Wang J, Andrae B, Sundström K, Ström P, Ploner A, Elfström KM, Arnheim-Dahlström L, Dillner J, Sparén P. BMJ; 2016 Feb 11; 352():i276. PubMed ID: 26869597 [Abstract] [Full Text] [Related]
3. Detection of high grade squamous intraepithelial lesions and tumors using the AutoPap System: results of a primary screening clinical trial. Wilbur DC, Prey MU, Miller WM, Pawlick GF, Colgan TJ, Dax Taylor D. Cancer; 1999 Dec 25; 87(6):354-8. PubMed ID: 10603189 [Abstract] [Full Text] [Related]
4. Comparative sensitivities of ThinPrep and Papanicolaou smear for adenocarcinoma in situ (AIS) and combined AIS/high-grade squamous intraepithelial lesion (HSIL): comparison with HSIL. Roberts JM, Thurloe JK. Cancer; 2007 Dec 25; 111(6):482-6. PubMed ID: 17969065 [Abstract] [Full Text] [Related]
8. Atypical endocervical glandular cells: accuracy of cytologic diagnosis. Lee KR, Manna EA, St John T. Diagn Cytopathol; 1995 Oct 25; 13(3):202-8. PubMed ID: 8575278 [Abstract] [Full Text] [Related]
9. HPV detection rates and histopathologic follow-up of patients with HSIL cytology in a large academic women's hospital laboratory. Ashman D, Zhang H, Li J, Austin M, Wang T, Pradhan D, Zhao C. J Am Soc Cytopathol; 2020 Oct 25; 9(6):550-555. PubMed ID: 32475726 [Abstract] [Full Text] [Related]
11. Cervical Screening Results Leading to Detection of Adenocarcinoma in Situ of the Uterine Cervix. Srisomboon S, Tantipalakorn C, Charoenkwan K, Srisomboon J. Asian Pac J Cancer Prev; 2019 Feb 26; 20(2):377-382. PubMed ID: 30803195 [Abstract] [Full Text] [Related]
16. Review of negative and low-grade cervical smears in women with invasive cervical cancer after the first 3 years of the national cervical screening programme in Slovenia. Repše-Fokter A, Pogačnik A, Snoj V, Primic-Žakelj M, Fležar MS. Cytopathology; 2012 Feb 26; 23(1):23-9. PubMed ID: 20964743 [Abstract] [Full Text] [Related]
19. Papanicolaou smear history in women with low-grade cytology before cervical cancer diagnosis. Bofin AM, Nygård JF, Skare GB, Dybdahl BM, Westerhagen U, Sauer T. Cancer; 2007 Aug 25; 111(4):210-6. PubMed ID: 17567833 [Abstract] [Full Text] [Related]
20. Benefit and burden in the Dutch cytology-based vs high-risk human papillomavirus-based cervical cancer screening program. Loopik DL, Koenjer LM, Siebers AG, Melchers WJG, Bekkers RLM. Am J Obstet Gynecol; 2021 Feb 25; 224(2):200.e1-200.e9. PubMed ID: 32800820 [Abstract] [Full Text] [Related] Page: [Next] [New Search]